Callan JMB (NASDAQ:CJMB) Releases Earnings Results

Callan JMB (NASDAQ:CJMB) issued its quarterly earnings results on Friday. The company reported ($0.59) EPS for the quarter, Zacks reports. Callan JMB had a negative return on equity of 166.44% and a negative net margin of 139.14%.

Callan JMB Stock Performance

Callan JMB stock traded up $0.01 during trading on Friday, reaching $1.01. The company had a trading volume of 16,104 shares, compared to its average volume of 105,185. Callan JMB has a 12-month low of $0.86 and a 12-month high of $5.88. The stock’s 50 day moving average price is $1.37 and its two-hundred day moving average price is $1.93. The firm has a market capitalization of $5.69 million, a price-to-earnings ratio of -0.56 and a beta of 0.35.

Insider Transactions at Callan JMB

In other news, insider David J. Croyle purchased 14,805 shares of the stock in a transaction on Friday, March 6th. The stock was purchased at an average price of $1.76 per share, with a total value of $26,056.80. Following the completion of the transaction, the insider owned 789,805 shares in the company, valued at approximately $1,390,056.80. The trade was a 1.91% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 73.87% of the company’s stock.

Institutional Investors Weigh In On Callan JMB

A hedge fund recently raised its stake in Callan JMB stock. Creative Planning raised its position in shares of Callan JMB Inc. (NASDAQ:CJMB) by 41.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 170,008 shares of the company’s stock after acquiring an additional 50,000 shares during the period. Creative Planning owned approximately 3.79% of Callan JMB worth $830,000 at the end of the most recent reporting period.

Analyst Ratings Changes

A number of equities research analysts have recently commented on CJMB shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Callan JMB in a report on Wednesday, April 29th. Wall Street Zen raised Callan JMB to a “hold” rating in a research report on Saturday, March 28th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Callan JMB has an average rating of “Sell”.

Callan JMB Company Profile

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.